Evaluation of tumor-infiltrating lymphocytes and mammographic density as predictors of response to neoadjuvant systemic therapy in breast cancer-Reference-Cited by-同舟云学术

Evaluation of tumor-infiltrating lymphocytes and mammographic density as predictors of response to neoadjuvant systemic therapy in breast cancer

Published:2023-11-07 Issue:12 Volume:62 Page:1862-1872
ISSN:0284-186X
Container-title:Acta Oncologica
language:en
Short-container-title:Acta Oncologica

Author:

Landén Amalia H.¹^ORCID,Chin Kian²^ORCID,Kovács Anikó³^ORCID,Holmberg Erik¹^ORCID,Molnar Eva⁴,Stenmark Tullberg Axel¹^ORCID,Wärnberg Fredrik²^ORCID,Karlsson Per¹^ORCID

Affiliation:

1. Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden

2. Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden

3. Department of Clinical Pathology, Sahlgrenska University Hospital, Gothenburg, Sweden

4. Department of Radiology, Sahlgrenska University Hospital, Gothenburg, Sweden

Funder

Swedish Cancer Society

Swedish Research Council

Swedish governmental ALF agreement

Publisher

Medical Journals Sweden AB

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/0284186X.2023.2274483

Reference53 articles.

1. St. Gallen/Vienna 2021: A Brief Summary of the Consensus Discussion on Customizing Therapies for Women with Early Breast Cancer

2. Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials

3. Neoadjuvant Versus Adjuvant Systemic Treatment in Breast Cancer: A Meta-Analysis

4. Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy

5. Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer